As Covid-19 infections soar across China, a shortage of antiviral medicines like Pfizer Inc.’s Paxlovid appears to be spurring people to turn to the black market. Know more:
As Covid-19 infections soar across China, a shortage of antiviral medicines like Pfizer Inc.’s Paxlovid appears to be spurring people to turn to the black market.
One user on the popular Twitter-like Weibo platform said on Sunday that she was buying generic Paxlovid made in Bangladesh because she had an elderly relative and couldn’t get hold of any in China. She said in the post, which has been removed, that while she’d heard China had imported tens of thousands of boxes of Paxlovid, ordinary residents weren’t able to access the potentially life-saving medicine.
Even going by the book can come at a hefty price, depending on where someone seeks treatment. Guangzhou Daily reported that a staff member at the private Guangzhou United Family Hospital said Paxlovid costs about 2,300 yuan, but patients need a raft of tests in order to determine their suitability for the medication.
When China was still trying to keep out the virus, securing adequate supplies of antivirals was described by top health officials like Liang Wannian as essential before the country would consider reopening. The sudden about-turn on Covid means that the under-vaccinated elderly population that benefit most from such drugs are highly vulnerable.
Pfizer said in a statement that it’s collaborating with all stakeholders to secure an adequate supply of Paxlovid in China and remains committed to fulfilling the treatment needs of patients in the country and around the world. It said it’s committed to bringing medicines and therapies including Paxlovid that will benefit Chinese patients as soon as possible.
Merck & Co.’s molnupiravir isn’t approved, though in September it said it struck a deal with a state-owned drugmaker to import and market the pill.As part of efforts to provide generic low-cost antivirals to developing countries, the United Nations-backed Medicines Patent Pool program in March authorized five Chinese companies to make Paxlovid, but exclusively for export. The group includes Huahai, which struck a separate deal with Pfizer to make Paxlovid for China’s domestic market.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer working to send COVID pill Paxlovid to China – CNBCPfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday. | Reuters
Read more »
Workers clash with police at COVID-19 test kit factory in ChinaScores of workers have clashed with police at a COVID-19 test kit factory in China, video spreading on social media showed Sunday, as the country navigates a path out of its hardline virus policy.
Read more »
China reopens borders in final farewell to zero-COVIDTravelers streamed into China by air, land and sea, many eager for long-awaited reunions, as Beijing opened borders that have been all but shut since the start of the COVID-19 pandemic. | Reuters
Read more »
China reopens borders in final farewell to zero-COVIDHONG KONG/BEIJING — Travelers streamed into China by air, land, and sea on Sunday, many eager for long-awaited reunions, as Beijing opened borders that have been all but shut since the start of
Read more »
'Life is moving forward': China declares new COVID-19 phaseChina braces for a 'new phase' in its battle against COVID-19 after it dropped pandemic border controls in its latest easing of virus curbs.
Read more »
90% of people in China province infected with COVID-19–officialAlmost 90 percent of people in China’s third most populous province have now been infected with Covid-19, a top official said Monday, as the country battles an unprecedented surge in cases. | AFP
Read more »